Compounds > pyrimidine
Page last updated: 2024-08-21

pyrimidine and Adverse Drug Event

pyrimidine has been researched along with Adverse Drug Event in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hertz, DL; Sahai, V1
Blanco, C; García, MI; García-Alfonso, P; García-González, X; Grávalos, C; Iglesias, I; Longo, F; López-Fernández, LA; Martínez, J; Martínez, V; Pachón, V; Pellicer, M; Robles, L; Rueda, D; Salvador, S; Sanjurjo, M1
Altavilla, G; Barbara, C; Bordonaro, R; Butera, A; Cinieri, S; Cremolini, C; Crucitta, S; Danesi, R; De Braud, F; Del Re, M; Di Donato, S; Di Leo, A; Falcone, A; Latiano, TP; Loupakis, F; Maiello, E; Mazzotti, V; Michelucci, A; Morganti, R; Passardi, A; Pietrantonio, F; Pinto, C; Salvadori, S; Schirripa, M; Simi, P; Zamagni, C1

Other Studies

3 other study(ies) available for pyrimidine and Adverse Drug Event

ArticleYear
Including DPYD on Cancer Genetic Panels to Prevent Fatal Fluoropyrimidine Toxicity.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2020, Volume: 18, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Drug-Related Side Effects and Adverse Reactions; Genetic Testing; Humans; Mutation; Neoplasms; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Prognosis; Pyrimidines; Treatment Outcome

2020
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity.
    Pharmacogenomics, 2017, Volume: 18, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Capecitabine; Colorectal Neoplasms; Drug-Related Side Effects and Adverse Reactions; Exome; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines

2017
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
    The pharmacogenomics journal, 2019, Volume: 19, Issue:6

    Topics: Alleles; Cohort Studies; Dihydrouracil Dehydrogenase (NADP); Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines

2019